Drawing for EMPATICA

USPTO serial 79203827

EMPATICA

Reviewed by CopyMark Law Group

Reg. 5499800Status 706Registered
Filing date
Status date
Registration date
Jun 26, 2018
Examiner
SCHWAB, MATTHEW DAVID
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with EMPATICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal St.Alexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
005Bracelets for medical purposes; bracelets for the medical research sector for medical purposes; magnetic bracelets for medical purposes; adhesive bandages for medical purposesACTIVE—
009Apparatus for scientific and laboratory research or use as educational apparatus and simulators, not for medical use, namely, wearable sensors for gathering and recording of human biometric physiological parameters; sensors and detectors, namely, accelerometers, temperature sensors, and gyroscopes; hardware interface boards, namely, interface cards for data processing equipment in the form of printed circuits; electric sensors; data communications hardware, namely, computer hardware for communicating audio, video and data between computers via a global computer network, wide-area computer networks, and peer-to-peer computer networksACTIVE—
010Apparatus for medical and scientific research, namely, heart rate monitoring apparatus, health monitors comprising electrodermal activity sensors, blood pressure monitoring devices, electronic temperature monitors for medical use, diagnostic apparatus for medical purposes, namely, diagnostic apparatus for the detection of seizures and sleep disorders, patient monitoring sensors, medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate, and respiratory events, portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device, sensors for medical use to be worn by a human to gather human biometric data and also including sensors, accelerometers, and gyroscopes sold as a unit, electronic analyzers for medical diagnostics, namely, activity sensors and monitors to detect and analyze epilepsy rates attendant to various activities, health monitors comprising activity sensors, electronic monitoring instruments for medical use, namely, electronic temperature monitors for medical use, heartbeat measuring apparatus, blood pressure measuring devices; electronic devices for monitoring blood pressure; medical products, namely, precision sensors for medical use being medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate, and respiratory events; electric medical instruments for recording heart activity, changes in vital signs, blood pressure, heart rates, respiratory events; Medical electrodes for picking up biological parametersACTIVE—
035Compilation of statistical data for use in scientific research; compilation of statistical data relating to medical researchACTIVE—
042Biomedical research; engineering research, namely, scientific and technological research in the field of engineering; pharmaceutical research; scientific research; technical research in the field of engineering and pharmaceuticals; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in relation to medical research; clinical research in the field of neurology with the main focus in the epilepsy field; medical research; research on the subject of pharmaceuticals; scientific research for medical purposes; scientific research in the field of pharmacy; computer hardware consultancy, namely, consultancy in the design and development of computer hardwareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 3, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Oct 3, 202471AGREGISTERED-SEC.71 ACCEPTED—
Sep 29, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 29, 2024ES71TEAS SECTION 71 RECEIVED—
Jun 26, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 16, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 19, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 27, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 27, 2018FIMPFINAL DISPOSITION PROCESSED—
Sep 26, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 26, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 10, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 10, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 6, 2018GPNXNOTIFICATION PROCESSED BY IB—
Mar 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 6, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 5, 2018ALIEASSIGNED TO LIE—
Feb 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Dec 29, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 29, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 29, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 29, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 29, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Dec 29, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 29, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 29, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 31, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 31, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Oct 31, 2017CNSLSUSPENSION LETTER WRITTEN—
Sep 28, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 28, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 31, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 30, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 29, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2017DOCKASSIGNED TO EXAMINER—
Mar 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance